Shinichiro Ochi

1.5k total citations
62 papers, 881 citations indexed

About

Shinichiro Ochi is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Shinichiro Ochi has authored 62 papers receiving a total of 881 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 18 papers in Molecular Biology and 16 papers in Psychiatry and Mental health. Recurrent topics in Shinichiro Ochi's work include Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Shinichiro Ochi is often cited by papers focused on Alzheimer's disease research and treatments (13 papers), Dementia and Cognitive Impairment Research (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (9 papers). Shinichiro Ochi collaborates with scholars based in Japan and United States. Shinichiro Ochi's co-authors include Shuichi Ueno, Yuta Yoshino, Jun‐ichi Iga, Kiyohiro Yamazaki, Takaaki Mori, Yogesh Dwivedi, Yuki Ozaki, Taku Yoshida, Tomoko Sao and Yoko Mori and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Shinichiro Ochi

59 papers receiving 867 citations

Peers

Countries citing papers authored by Shinichiro Ochi

Since Specialization

Citations

This map shows the geographic impact of Shinichiro Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichiro Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichiro Ochi more than expected).

Fields of papers citing papers by Shinichiro Ochi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichiro Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichiro Ochi. The network helps show where Shinichiro Ochi may publish in the future.

Co-authorship network of co-authors of Shinichiro Ochi

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichiro Ochi. A scholar is included among the top collaborators of Shinichiro Ochi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichiro Ochi. Shinichiro Ochi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blood RNA transcripts show changes in inflammation and lipid metabolism in Alzheimer's disease and mitochondrial function in mild cognitive impairment 2024 ·Journal of Alzheimer s Disease Reports ·Jun‐ichi Iga, Yuta Yoshino, (unknown), (unknown), (unknown), (unknown), Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Masakatsu Yamashita, Shuichi Ueno	1
2	Behavioral and psychological symptoms and brain volumes in community-dwelling older persons from the Nakayama Study 2024 ·Scientific Reports ·(unknown), Jun‐ichi Iga, (unknown), Yuta Yoshino, Kiyohiro Yamazaki, Shinichiro Ochi, Kentaro Kawabe, Fumie Horiuchi, Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Yasuko Tatewaki, Yasuyuki Taki, Toshiharu Ninomiya, Shu-ichi Ueno	0
3	Aberrant Expression of GABA-Related Genes in the Hippocampus of 3xTg-AD Model Mice from the Early to End Stages of Alzheimer’s Disease 2023 ·Journal of Alzheimer s Disease ·Hiroaki Mori, Yuta Yoshino, Jun‐ichi Iga, Shinichiro Ochi, (unknown), Kiyohiro Yamazaki, (unknown), Yuki Ozaki, Shuichi Ueno	5
4	Analysis of factors related to cognitive impairment in a community‐based, complete enumeration survey in Japan: the Nakayama study 2023 ·Psychogeriatrics ·Taku Yoshida, Takaaki Mori, Hideaki Shimizu, (unknown), Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Yuki Ozaki, Kentaro Kawabe, Fumie Horiuchi, Kenjiro Komori, Jun‐ichi Iga, Shuichi Ueno	3
5	Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals 2023 ·Molecular Psychiatry ·Shinichiro Ochi, Bhaskar Roy, (unknown), Richard C. Shelton, Yogesh Dwivedi	23
6	Effects of gestational haloperidol exposure on mRNA expressions related to glutamate and GABA receptors in offspring 2023 ·IBRO Neuroscience Reports ·(unknown), Yuta Yoshino, (unknown), Shinichiro Ochi, Jun‐ichi Iga, Shuichi Ueno	0
7	5-HT_1A Partial Agonist Tandospirone for Behavioral and Psychological Symptoms in Oldest-old Patients with Dementia at a Special Elderly Nursing Home 2021 ·Clinical Psychopharmacology and Neuroscience ·Shinichiro Ochi, Takaaki Mori, Jun‐ichi Iga, Shuichi Ueno	1
8	Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases 2021 ·Journal of Alzheimer s Disease ·Hiroaki Mori, (unknown), Yuta Yoshino, (unknown), (unknown), Kiyohiro Yamazaki, Shinichiro Ochi, (unknown), Taku Yoshida, Hideaki Shimizu, Takaaki Mori, Jun‐ichi Iga, Shuichi Ueno	11
9	Hypoglycemia with atypical antipsychotics, but not with typical antipsychotics: A case report 2020 ·Shinichiro Ochi, Masao Abe, Hideaki Shimizu, Jun‐ichi Iga, Shuichi Ueno	1
10	<p>ABCA7 Gene Expression and Genetic Association Study in Schizophrenia</p> 2020 ·Neuropsychiatric Disease and Treatment ·Kiyohiro Yamazaki, Yuta Yoshino, Kentaro Kawabe, (unknown), Shinichiro Ochi, Yoko Mori, Yuki Ozaki, Shusuke Numata, Jun‐ichi Iga, Tetsuro Ohmori, Shuichi Ueno	3
11	PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression 2020 ·Journal of Alzheimer s Disease ·(unknown), Yuta Yoshino, (unknown), Hiroaki Mori, Mariko Ueno, Yuki Ozaki, Kiyohiro Yamazaki, Shinichiro Ochi, Takaaki Mori, Jun‐ichi Iga, Masahiro Nagai, Masahiro Nomoto, Shuichi Ueno	17
12	Identifying Blood Transcriptome Biomarkers of Alzheimer’s Disease Using Transgenic Mice 2020 ·Molecular Neurobiology ·Shinichiro Ochi, Jun‐ichi Iga, (unknown), Yuta Yoshino, Kiyohiro Yamazaki, (unknown), Hiroaki Mori, Yuki Ozaki, Takaaki Mori, Shuichi Ueno	18
13	Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report 2019 ·Clinical Psychopharmacology and Neuroscience ·Shinichiro Ochi, (unknown), Yuta Yoshino, Hideaki Shimizu, Jun‐ichi Iga, Shuichi Ueno	2
14	Analysis of methylation and -141C Ins/Del polymorphisms of the dopamine receptor D2 gene in patients with schizophrenia 2019 ·Psychiatry Research ·(unknown), Yuta Yoshino, Kiyohiro Yamazaki, (unknown), Yoko Mori, Takaaki Mori, Shinichiro Ochi, Jun‐ichi Iga, Shuichi Ueno	15
15	DNA methylation changes at TREM2 intron 1 and TREM2 mRNA expression in patients with Alzheimer's disease 2017 ·Journal of Psychiatric Research ·Yuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, Tomoko Sao, Yoko Mori, Shinichiro Ochi, Taku Yoshida, Takaaki Mori, Jun‐ichi Iga, Shuichi Ueno	68
16	TREM2 mRNA Expression in Leukocytes Is Increased in Alzheimer’s Disease and Schizophrenia 2015 ·PLoS ONE ·Yoko Mori, Yuta Yoshino, Shinichiro Ochi, Kiyohiro Yamazaki, Kentaro Kawabe, Masao Abe, (unknown), Yuki Ozaki, Taku Yoshida, Shusuke Numata, Takaaki Mori, Jun‐ichi Iga, (unknown), Tetsuro Ohmori, Shuichi Ueno	34
17	Distribution of D-3-aminoisobutyrate-pyruvate aminotransferase in the rat brain 2014 ·BMC Neuroscience ·Masao Abe, Shinichiro Ochi, Yoko Mori, Kiyohiro Yamazaki, (unknown), Yuta Yoshino, Ryuji Fukuhara, Satoshi Tanimukai, Seiji Matsuda, Shuichi Ueno	3
18	The nicotinic cholinergic system is affected in rats with delayed carbon monoxide encephalopathy 2014 ·Neuroscience Letters ·Shinichiro Ochi, Masao Abe, Cheng Li, Yoko Mori, (unknown), Yuta Yoshino, Kiyohiro Yamazaki, Takaaki Mori, Ryuji Fukuhara, Satoshi Tanimukai, Seiji Matsuda, Kenichi Yoshida, Shuichi Ueno	20
19	A case study: neuroleptic malignant syndrome with risperidone and CYP2D6 gene variation 2011 ·General Hospital Psychiatry ·Shinichiro Ochi, (unknown), Masao Abe, Ryuji Fukuhara, (unknown), Kentaro Kawabe, Shuichi Ueno	7
20	Effectiveness of second-generation antipsychotics with acute-phase schizophrenia 2009 ·Schizophrenia Research ·Kotaro Hatta, Koji Sato, Hiroshi Hamakawa, (unknown), Naoto Kimura, Shinichiro Ochi, Yasuhiko Sudo, Nozomu Asukai, Hiroyuki Nakamura, Chie Usui, (unknown), Toyoaki Hirata, (unknown)	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact